Authors:
CLARKE R
BREEZE E
SHERLIKER P
SHIPLEY M
YOUNGMAN L
FLETCHER A
FUHRER R
LEON D
PARISH S
COLLINS R
MARMOT M
Citation: R. Clarke et al., DESIGN, OBJECTIVES, AND LESSONS FROM A PILOT 25-YEAR FOLLOW-UP RE-SURVEY OF SURVIVORS IN THE WHITEHALL STUDY OF LONDON CIVIL-SERVANTS, Journal of epidemiology and community health, 52(6), 1998, pp. 364-369
Authors:
DILLNER J
LEHTINEN M
BJORGE T
LUOSTARINEN T
YOUNGMAN L
JELLUM E
KOSKELA P
GISLEFOSS RE
HALLMANS G
PAAVONEN J
SAPP M
SCHILLER JT
HAKULINEN T
THORESEN S
HAKAMA M
Citation: J. Dillner et al., PROSPECTIVE SEROEPIDEMIOLOGIC STUDY OF HUMAN-PAPILLOMAVIRUS INFECTIONAS A RISK FACTOR FOR INVASIVE CERVICAL-CANCER, Journal of the National Cancer Institute, 89(17), 1997, pp. 1293-1299
Authors:
BJORGE T
DILLNER J
ANTTILA T
ENGELAND A
HAKULINEN T
JELLUM E
LEHTINEN M
LUOSTARINEN T
PAAVONEN J
PUKKALA E
SAPP M
SCHILLER J
YOUNGMAN L
THORESEN S
Citation: T. Bjorge et al., PROSPECTIVE SEROEPIDEMIOLOGICAL STUDY OF ROLE OF HUMAN-PAPILLOMAVIRUSIN NON-CERVICAL ANOGENITAL CANCERS, BMJ. British medical journal, 315(7109), 1997, pp. 646-649
Authors:
BJORGE T
HAKULINEN T
ENGELAND A
JELLUM E
KOSKELA P
LEHTINEN M
LUOSTARINEN T
PAAVONEN J
SAPP M
SCHILLER J
THORESEN S
WANG ZH
YOUNGMAN L
DILLNER J
Citation: T. Bjorge et al., A PROSPECTIVE, SEROEPIDEMIOLOGICAL STUDY OF THE ROLE OF HUMAN-PAPILLOMAVIRUS IN ESOPHAGEAL CANCER IN NORWAY, Cancer research, 57(18), 1997, pp. 3989-3992
Authors:
PARISH S
COLLINS R
PETO R
YOUNGMAN L
BARTON J
JAYNE K
CLARKE R
APPLEBY P
LYON V
CEDERHOLMWILLIAMS S
MARSHALL J
SLEIGHT P
Citation: S. Parish et al., CIGARETTE-SMOKING, TAR YIELDS, AND NONFATAL MYOCARDIAL-INFARCTION - 14000 CASES AND 32000 CONTROLS IN THE UNITED-KINGDOM, BMJ. British medical journal, 311(7003), 1995, pp. 471-477
Authors:
KEECH A
COLLINS R
MACMAHON S
ARMITAGE J
LAWSON A
WALLENDSZUS K
FATEMIAN M
KEARNEY E
LYON V
MINDELL J
MOUNT J
PAINTER R
PARISH S
SLAVIN B
SLEIGHT P
YOUNGMAN L
PETO R
Citation: A. Keech et al., 3-YEAR FOLLOW-UP OF THE OXFORD-CHOLESTEROL-STUDY - ASSESSMENT OF THE EFFICACY AND SAFETY OF SIMVASTATIN IN PREPARATION FOR A LARGE MORTALITY STUDY, European heart journal, 15(2), 1994, pp. 255-269
Authors:
HUNT D
VARIGOS J
DIENSTL F
LECHLEITNER P
DEBACKER G
KORNITZER M
CAIRNS J
TURPIE A
FRITZHANSEN P
SKAGEN K
KALA R
HEIKKILA J
BOISSEL JP
LEIZOROVICZ A
SCHRODER R
KOTHE K
KARATZAS N
HORGAN J
OCALLAGHAN D
TOGNONI G
FRANZOSI MG
MAGGIONI A
COHEN A
KOSTER R
WHITE H
MACMAHON S
KJEKSHUS J
REIKVAM A
CEREMUZYNSKI L
PAOLASSO E
DIAZ R
VALENTIN V
WILHELMSEN L
LUNDKVIST L
MOCCETTI T
MALACRIDA R
GENONI M
COLLINS R
SLEIGHT P
PETO R
PARISH S
DOLL R
ARMITAGE P
CEDERHOLMWILLIAMS S
CONWAY M
DOVE P
FLATHER M
MARSHALL J
YOUNGMAN L
JULIAN D
CHAMBERLAIN D
WARLOW C
SANDERCOCK P
FOX K
HENNEKENS C
GOLDHABER S
TIMMIS G
YUSUF S
MEIER P
Citation: D. Hunt et al., ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 339(8796), 1992, pp. 753-770